Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Trebananib

EU orphan designation number: EU/3/13/1207   
Active ingredient: Trebananib
Indication: Treatment of ovarian cancer
Sponsor: Amgen Europe B.V.
Minervum 7061, NL-4817 ZK Breda, Nederland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/11/2013 Centralised Orphan - Designation EMA/OD/122/13 (2013)8054 of 13/11/2013